Funded Startups in Lund
Across the 44 most recent disclosed rounds for Lund-based startups, the largest disclosed amount is Asgard Therapeutics’ $33M on 2024-03-14.
Across the 44 most recent disclosed rounds for Lund-based startups, the largest disclosed amount is Asgard Therapeutics’ $33M on 2024-03-14. That single $33M round dwarfs most other disclosed rounds in the listing, where many reported sizes cluster between the low hundreds of thousands and single-digit millions (for example, $420K on 2024-05-17 for Phase Holographic Imaging, and $8M on 2026-02-11 for Yazen). On staging, “Series Unknown” appears repeatedly (22 of 44 rows) and “undisclosed” amounts appear in 3 rows (Cocoon Airbag Protection on 2024-09-19, EpinovaTech on 2024-05-14, and DealGuru on 2024-01-11), making disclosed-size comparisons uneven.
Timing is concentrated: the most recent entry is Emulsi Biotech on 2026-06-16 ($740K), and the span for these 44 rows runs from 2021-02-15 (Sanctify Financial Technologies, $900K) through 2026-06-16. Sector-wise, Biotechnology shows up in at least 13 entries, forming the largest concentration relative to other recurring categories like Health Care and AI (both present but with less density than Biotechnology).
Most recent rounds
44 shownRelated listings
Frequently asked
What stands out by deal size in Lund—does one round dominate the disclosed amounts?
Yes. Asgard Therapeutics’ $33M (2024-03-14) is the only disclosed round above the $10M mark in this set; the next-largest disclosed amounts are Yazen at $8M (2026-02-11) and Zerotude at $8M (2024-11-04), with many other disclosed rounds at $4M or below (e.g., $2M at multiple dates).
How concentrated are rounds in the most recent window of time?
Recent activity clusters tightly at the top of the list: the entries from 2026-05-04 through 2026-06-16 include Alligator Bioscience ($2M on 2026-05-05), BiBBInstruments ($5M on 2026-04-13), ChemoTech ($640K on 2026-06-02), and Emulsi Biotech ($740K on 2026-06-16). That creates a dense late-2026 run compared with the earlier spread down to 2021-02-15.
Which stage labels dominate, and how does that affect interpreting the funding sizes?
“Series Unknown” accounts for 22 of 44 rows, while amounts are “undisclosed” in 3 rows (Cocoon Airbag Protection, EpinovaTech, DealGuru). This means a large share of the list limits stage-specific or size-specific benchmarking—for example, several large-looking rounds still sit under “Series Unknown,” such as Yazen ($8M on 2026-02-11) and Zerotude ($8M on 2024-11-04).
Are there sector concentrations that would influence outreach targeting in Lund?
Biotechnology is the clearest concentration with at least 13 entries, including Emulsi Biotech ($740K, 2026-06-16), Alligator Bioscience ($2M, 2026-05-05), and Enzymatica ($13M, 2024-09-12). Health Care is also present frequently (e.g., ChemoTech $640K on 2026-06-02 and PharmNovo $7M on 2022-07-03), but the Biotechnology density is higher in the rows shown.
Which entries are notable outliers besides the biggest disclosed round?
Apart from the $33M outlier (Asgard Therapeutics, 2024-03-14), the lowest disclosed amount is Parlametric at $40K on 2023-05-17, which sits far below the rest of the disclosed-size range (e.g., $420K for Phase Holographic Imaging on 2024-05-17 and $580K for Qlucore on 2025-06-24). The “undisclosed” entries also form a separate outlier group where size comparisons can’t be made (Cocoon Airbag Protection on 2024-09-19, EpinovaTech on 2024-05-14, DealGuru on 2024-01-11).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.